Top Wall Street Research Team Makes ZBH #1 Pick for 2021

Zimmer Biomet and Canary Medical Inc. to launch smart knee implant in 2021.

View the entire article here.


Two Wall Street analysts, Mike Matson, CFA, and David Saxon, CFA, from Needham & Company, LLC have selected Zimmer Biomet Holdings, Inc. as their top pick for 2021.

Matson and Saxon selection of Zimmer Biomet as a top pick for 2021 comes on the heels of a very interesting announcement by ZBH regarding its latest technology move—specifically ZBH’s acquisition of a novel smart implant technology which Matson and Saxon think could become a “significant growth driver.”

That technology comes from Zimmer Biomet’s arrangement with Canary Medical Inc. and the plan in 2021 is to launch a remarkable smart knee implant to collect and analyst real-time knee data and communicate that to the patient’s care team via the cloud. This cutting edge technology, says ZBH, will be incorporated into a Persona-IQ smart knee, which Matson and Saxon believe could be the first smart knee implant to market.

View the entire article here.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email